Implementation of DOT statutes 49 U.S.C.  41310(A), 49 U.S.C.  44902(B), 49 U.S.C.  41501, and 49 U.S.C.  41704, regarding cargo transport. Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests, including the discussion draft of the Diagnostic Accuracy and Innovation Act (DAIA), FDAs technical assistance on DAIA, and the discussion draft of the Verifying Accurate Leading-edge IVCT Development (VALID) Act; Medicare coverage and reimbursement levels for laboratory services and reforms to the Clinical Laboratory Fee Schedule; federal policy relating to drug development; federal policy relating to surprise medical bills, including the discussion draft of the Protecting Patients from Surprise Medical Billing Act; and H.R. 7083, the Access to Genetic Counselor Services Act.
TRA - Transportation HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
LABORATORY CORPORATION OF AMERICA HOLDINGS
531 South Spring Street, Burlington, NC, 27215, US
DONALD HORTON KATHERINE PREGEL DONALD HORTON KATHERINE PREGEL